RxDoctor Payments Data

Svetlana Chehet

Family · Neptune, NJNPI 1265837892

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,920 of the $8,840 with a category attached, or 89.6%. It is spread thinly across 26 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,688 and has fallen 60.7% since, to $1,056 in 2025. Among family clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,840in general payments, 2019–2025

Across 423 payments — averaging $20.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Lilly USA, LLC$521
  • Incyte Corporation$425
  • Sanofi$424
  • plus $4K from 20 others

What the payments were for

  • Speaking & faculty fees$1572%
  • Food & beverage$7,92090%
  • Education$7639%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,840 in reported general payments places this provider in the 95th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Medicare billing

Part B allowed, 2024
$261,284
Medicare patients
322
Services billed
2,711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$49,240
Betamethasone Dipropionate81$3,396
Tacrolimus27$2,421
Ketoconazole137$2,242
Fluocinolone Acetonide38$1,518
Metronidazole29$1,252
Clobetasol Propionate22$1,136
Doxycycline Hyclate67$771
Triamcinolone Acetonide77$446
Fluocinolone AcetonideFluocinolone/Shower Cap12$446
Clindamycin Phosphate13$418
Ammonium Lactate35$347
Minoxidil39$341
Mupirocin35$265
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc16$253

Paid to pharmacies, not to this prescriber.

Other family in Neptune

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →